市場調查報告書
商品編碼
1395957
植入式連接埠市場:規模、細分市場、份額、法規、報銷、程序、到 2033 年的預測Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
植入式端口用於需要化療的患者。 用作中心靜脈導管的替代品。 它也用於將藥物注射到靜脈中並抽血。 也稱為留置連接埠或皮下連接埠。 每次治療後,少量液體會被沖入導管,以防止導管阻塞。 如果連接埠不經常使用,則應每 4 至 6 週清潔一次。
本報告深入探討了全球植入式連接埠市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。我是。
Implantable Ports Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Drug Delivery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Implantable Ports market for the year 2020 and beyond. Implantable ports are used on the patients who require chemotherapy. They are used as a substitute to the central venous catheters. They can be also used for injecting medicine into the vein or to take blood. They are also called as portacaths or subcutaneous ports. After each treatment, a small amount of fluid is flushed into the catheter so it does not get blocked. The port will need to be flushed every 4 to 6 weeks if it is not being used regularly.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Implantable Ports and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Becton Dickinson and Co, AngioDynamics Inc, B. Braun Melsungen AG, Teleflex Inc, Vygon SA, A.M.I. GmbH, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
The model will enable you to: